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Abstract:
 This article aims to review the current practice of recurrence prevention and intervention of adolescent depressive 
disorder in Thailand. In particular, we assess the Clinical Practice Guideline of Major Depressive Disorder for General 
Practitioners (CPG-MDD-GP) for Thailand, which is now the official guideline for all depressive patients who are children, 
adolescents, and adults in Thailand. Although this current Thai clinical guideline was developed and derived from the 
National Institute for Health and Care Excellence (NICE) of the United Kingdom and the recommendations and the practice 
parameters of the American Academy of Child and Adolescent Psychiatry (AACAP), it differs from these guidelines in a 
number of ways. Specifically, the main tool for the primary assessment of the Thai CPG-MDD-GP is called 9Q which 
categorizes the severity and follow-up of depressive symptoms by health care providers in a hospital setting, whereas the 
NICE guideline for depression in children and adolescents is based mainly on the community setting, and the AACAP 
parameter assesses patients by a direct interview method. Additionally, the Thai CPG-MDD-GP has no premise intervention 
for recurrence prevention of depression and lacks details regarding the importance of treatment engagement by family 
and community.
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Introduction
 Depression in young people has been a global 
health concern in the last decade. According to the National 
Institute of Mental Health,1 around 2.2 million adolescents 
between 12 and 17 years of age in the United State of America 
(USA) had at least one major depressive episode in the 
previous year. A study in Thailand reported that the 
prevalence of depression in adolescents was 14.9%.2
 According to the kindling hypothesis, longer 
episodes of depression can increase the risk for future 
subsequent episodes.3 Recurrent depression does not 
involve only neurobiological susceptibilities but also life 
stressors. In particular, the kindling hypothesis described 
the first episode of depression as associated more with 
psychosocial stressors than the following episodes which 
were influenced more by impaired neurobiological factors.4
 Recurrent depression during adolescence may 
represent life-long persistent depression that is associated 
with early manifestations of functional and interpersonal 
maladjustment.5 Hence, clinicians should carefully adjust 
their practice due to recurrent depression.6 However, no 
study on the prevention of recurrence and intervention of 
adolescent depression in Thailand has focused on 
psychological intervention in preventing the recurrence of 
depressive episodes in adolescents.
 Thus, this article review aims to appraise the studies 
and clinical practice of recurrence prevention and inter-
vention of Thai adolescent depressive disorder. However, 
this article has the limitation that only articles published 
in the English and Thai languages were included. The 
database of the Department of Mental Health of Thailand, 
Ministry of Public Health7 was searched in the Thai language 
for articles published between 1994 and 2014. The search 
terms were (1) depression, (2) psychosocial intervention, 
and (3) adolescent. The electronic search identified 18 poten-
tially relevant titles, but none of them were related to the 
prevention of recurrent depression in adolescents.
 At the present time, only the Thai Clinical Practice 
Guideline of Major Depressive Disorder for General Practi-
tioner (Thai CPG-MDD-GP) has been officially and widely 
used as the standard guideline for depression in Thailand.8 
To be relevant for the socio-economic context of Thailand, 
the guideline was modified from other standard guidelines 
including the National Institute for Clinical Excellence (NICE) 
of the United Kingdom (UK), the American Psychiatric Asso-
ciation: Practice Guideline for the Treatment of Patients with 
Major Depressive Disorder, and the World Federation of 
Societies of Biological Psychiatry (WFSBP) Guideline for 
Biological Treatment of Unipolar Depressive Disorders.
 This review article compares and appraises the 
prevention strategies of recurrence in adolescent depression 
using the Thai CPG-MDD-GP, National Institute for Health 
and Care Excellence,9 and the American Academy of Child 
and Adolescent Psychiatry (AACAP): Practice Parameter 
for the Assessment and Treatment of Children and 
Adolescents with Depressive Disorders.10 Since NICE9 and 
AACAP10 were prototypes for the overall service protocol in 
the Thai CPG-MDD-GP, they influence the clinical practice 
for the prevention of recurrent depression in children and 
young people not only in the UK or the USA, but also in 
Thailand and worldwide.
Thai CPG-MDD-GP
 The Thai CPG-MDD-GP is the current guideline 
for Thai general practitioners in primary and secondary 
care units where the capacities are 10 to 500 inpatients 
covering populations up to more than 10,000 people.8 
This wide gap of service capacity caused the protocol 
of management to be very brief and targets principally 
the pharmacological considerations in depression. How-
ever, some Thai university hospitals have psychological 
interventions for depressive children and adolescents, 
such as the child and adolescent psychiatric rehabilitation 
program at Siriraj Hospital (e.g., emotional regulation 
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training, social skills and communication training).11 These 
interventions are routinely practiced even though there are 
financial constraints and a lack of mental health personnel. 
 The Thai CPG-MDD-GP8 characterizes depression 
in children and adolescents as a special group for treatment 
using the same management protocol as adulthood 
depression (Figure 1). However, cognitive behavioral-therapy 
(CBT) and interpersonal therapy for depressed adolescents 
(IPT-A) were recommended as stand-alone interventions 
for mildly to moderately depressive children and adoles-
cents, while no psychotherapy was specifically mentioned 
for adulthood depression. Dissimilar to the AACAP,10 the 
Thai CPG-MDD-GP does not give any suggestions regarding 
the duration, frequency or protocol of psychological inter-
ventions.
Diagnosis of major depressive disorder
9Q Screening
Hospitalization criteria?
Refer to others Hospitalization Outpatient service
Yes No
Psychiatric services (fluoxetine 20 mg or sertraline 50 mg or amitriptyline 50 mg)
9Q score assessment Side-effect assessment
No Yes
Decreased score Change medicationManagement of non-responsive patients  Increased score 
Same dosage of medication
9Q score assessment
No response 
Increase dosage of medication
Partial response   Response  Continue medication 
 Follow-up for 1 year (by 9Q) until termination 
Figure 1 Brief protocol of major depressive disorder in Thailand (Thai CPG-MDD-GP)8
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 Even though the guideline is very up-to-date and 
covers all mainstream pharmacological agents for 
depression, no psychosocial dimension of management is 
mentioned in the guideline. The Thai CPG-MDD-GP has no 
section on the importance of family, school or community 
engagement in the treatment of depression. No family 
assessment or adjunctive psychoeducation12 is mentioned 
in this Thai clinical guideline of depression. All respon-
sibilities of depressive disorder care lie with the health 
care providers.
 The primary assessment tool is called the 9Q or the 
Thai version of the modified Patient Health Questionnaire. 
It categorizes the severity of depression using the same 
categories as in NICE 8 and AACAP 9 (i.e. mild, moderate 
and severe without psychotic symptoms).13 All depressive 
cases are assessed at the outpatient clinic by health care 
providers where antidepressants and other medications 
are prescribed. This is unlike Step 1 of the assessment which 
NICE9 points out is the responsibility of the personnel in 
a community context (Table 1). However, in cases of 
severe depression or psychotic depression, the Thai CPG-
MDD-GP states that patients should be assessed and
intervened at the inpatient unit.
 The Thai CPG-MDD-GP indicates that the 9Q is the 
only tool to assess treatment responses biweekly in 
the first month and every 4 weeks thereafter until the 
treatment is terminated. This process is different from 
the NICE Guideline 8 which points out that self-report 
questionnaires for depression in young people are to 
be used for routine screening of children older than 11 
years which relates to Child and Adolescent Mental 
Health Services (CAMHS) at Step 2 (Recognition).  
Table 1  Step-care model of depression in children and young people by the National Institute for Health and Care Excellence
Focus   Action Responsibility
 Detection Risk profiling Tier 1*
 Recognition Identification in presenting children or young people Tiers 2**–4****
 Mild depression (including dysthymia) Watchful waiting
  Non directive supportive therapy/group cognitive  Tier 1*
     behavioral therapy/guided self help Tier 1* or 2**
 Moderate to severe depression Brief psychological therapy Tier 2** or 3***
  +/– fluoxetine 
 Depression unresponsive to treatment/recurrent  Intensive psychological therapy
    depression/psychotic depression +/– fluoxetine, sertraline, citalopram, augmentation with Tier 3*** or 4**** 
     an antipsychotic 
Tier 1* practitioners working in universal services who are not mental health specialists
Tier 2** health-care provider teams in community and primary care settings 
Tier 3*** multidisciplinary teams in a community mental health setting or a child and adolescent psychiatry outpatient service
Tier 4**** intensive community treatment services, day units and inpatient units16
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 A 9Q score of <7 or a decrease of more than 50.0% 
would be classified as response-to-treatment cases in 
the Thai guideline. The clinical conditions of these patients 
are then followed up for 6 months before treatment 
termination. Even though the Thai CPG-MDD-GP notifies 
the healthcare provider for surveillance of a recurrent 
episode for 12 months following treatment termination, the 
Thai CPG-MDD-GP does not specify any practice for the 
prevention of recurrence in either adulthood or adolescent 
depression.
NICE: depression in children and young 
people9
 Above all, the stepped-care model by NICE states 
that treatment of depression in children and adolescents 
should be based in outpatient clinics or the community 
setting (Table 1). In order to improve long-standing remission 
and recovery outcomes, mental health care professionals 
should advise patients and their families of these four 
recommendations for long-term lifestyle modifications: (1) 
regular exercise program; (2) sleep hygiene; (3) anxiety 
management; and (4) a balanced diet. But in practice, NICE 
does not indicate specific suggestions, such as what life-
style they should modify, when to begin and when to terminate 
the modification, where individuals can ask for detailed 
advice, and how they can modify their lifestyle in a practical 
way.
 Step 1 (detection) states that the responsibilities of 
pre-recognition belong to the primary health care services, 
school, and other relevant community settings. These 
professionals are required to provide active listening and 
screening skills to provide support and prevent the persis-
tence of symptoms. NICE (2013) recommends that they 
should record early signs of depression and major life stress
for consideration of referral to CAMHS. If young people 
show any sign of progressive depression, they should 
be referred for rapid assessment through Step 2 or for 
recognition by CAMHS as soon as possible. In any case, 
surveillance for recurrence in the recovery period is not 
mentioned throughout these steps although the primary 
services and schools are the main resources of support 
during the recovery period. For these reasons, primary 
health care providers and school personnel should play 
larger roles in both the detection and prevention of 
occurrence and recurrence of depression. Even though 
Step 3 acknowledges that it is possible to recover from 
mild depression without any intervention, the guideline 
recommends 2 weeks of watchful waiting and that the 
choices of recommended psychosocial treatments (i.e. 
group cognitive behavioral-therapy (GCBT) or guided self-
help) should be discussed between the young people, 
their clinician, and their families at the first visit (NICE, 
2013). Even if the primary focus is to relieve acute depres-
sive symptoms, psychosocial intervention should be 
considered as part of the ongoing support to maintain 
symptom reduction and prevent recurrence. Therefore, 
psychosocial treatment considerations should not only be 
considered at Step 3 (mild depression) or at Step 4-5 
(moderate to severe depression), but emphasis should also 
be placed on the long-term effectiveness of recurrence 
prevention strategies. 
 In the case of moderate to severe depression in 
adolescents, combined pharmacotherapy with psycho-
social treatment is recommended. NICE (2013) specifies 
that individual CBT, IPT-A, family therapy, and psycho-
dynamic psychotherapy should be offered and discussed 
in Steps 4 and 5. While the guideline emphasizes the 
importance of evidence that supports specific pharmaco-
therapy in youths aged 12-17 years old, NICE (2013) does 
not mention any recommended particular psychosocial 
treatment in any age group.
 Following remission in Steps 4 and 5, the outcome 
can be either recovery or recurrent depression. NICE recom-
mends that CAMHS follow cases for 12 months after 
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remission. But the 12-month period may not be proper for 
follow-up in the recovery of depression in every adolescent.14 
In terms of the recurrence rate, Birmaher et al.15 reported 
30.0% of participants reported at least one recurrent 
depressive episode in up to 24 months following the 
completed treatment. This finding suggests that it may be 
more appropriate to follow the cases for a period of 24 
months in primary health care as indicated at Step 1 if 
there is a high risk of recurrence (i.e. early onset of 
depression, suicide or ADHD).   
 With respect to the core concept of the NICE 
guideline for community-based treatment of depression, 
prevention of recurrence should also be established in 
the immediate environment of the young people, such as 
at the school or primary care unit. Psychological inter-
vention should also be based on a time table and life-style 
to enhance compliance of treatment. According to most 
previous studies, GCBT as a prevention intervention 
conducted at school after class may be effective because 
the service assessment would be convenient. Hence, 
family members, peers, teachers, and those who live in 
the relevant community are the most important support 
system for mutual care. They should be engaged in the 
treatment not only at Step 1, but also in every step of care 
including recurrence prevention.     
AACAP: Practice Parameter for the 
Assessment and Treatment of Children and 
Adolescents with Depressive Disorders9
 Compared with the NICE guideline,9 the AACAP10 
allocates more responsibilities for both assessment and 
treatment of depression to the healthcare providers. The 
AACAP10 states that the routine duty of all involved 
clinical practitioners (e.g., school nurse, pediatrician, and 
general practitioner) is to screen depression in every 
child and adolescent whether they have had a prior 
depression episode or not. According to cognitive develop-
ment in this age group, clinicians should evaluate young 
people by using the direct interviewing method (face-to-
face) with the youths and their families.
 In the same way as the NICE guideline,9 the 
AACAP differentiates managements according to the 
severities of depression (i.e. mild, moderate, and severe 
depressive disorder). In preference to the stepped-care 
model, the AACAP divides the course of treatment into 
acute, continuous, and maintenance phases. Regarding 
AACAP’s primary goal, treatment response is defined as 
the absence of depressive disorder criteria and restoration 
of normal functioning (Figure 2). 
 The AACAP emphasizes more importance on 
psychosocial treatment with 4-6 weeks of supportive 
therapy (i.e. psychoeducation and case management) 
being described as the treatment of choice for mild depres-
sive disorder. In the cases of moderate to severe or recurrent 
depression, the AACAP recommends 6-8 weeks of CBT 
and interpersonal therapy. Severe depression in children 
and adolescents requires antidepressant alone or combined 
with psychotherapy. For example, individual CBT plus anti-
depressant use in adolescents with mild to moderate 
depression has been found to lead to a higher rate of 
remission. In cases of non-response to CBT or in combination 
with pharmacotherapy, the AACAP suggests that clinicians 
provide interpersonal and psychodynamic psychotherapy 
individually. 
 The AACAP guideline gives more details than the 
NICE regarding follow-up. The standard goal to achieve 
remission of depression symptoms is every young person 
with depressive disorder should be seen by a clinician 
every week for the first 4 weeks and then biweekly for 
a total of 12 weeks of treatment. However, the average 
duration to clinical recovery from the previous studies was 
22.8-27.0 weeks.14,15 Therefore, a 12-week follow-up 
duration may not be appropriate to assure remission and 
recovery of depression. Similar to the NICE guideline,9 a 
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12-month maintenance period may not be sufficient since 
the average time from remission to recurrent onset of 
depression was between 16.4 and 26.3 months.6      
 Even though the AACAP10 emphasizes the preven-
tion of recurrent depression in the maintenance phase, no 
specific psychological intervention was mentioned for this 
purpose in the AACAP practice parameter. Similar to the 
NICE guideline,9 the AACAP suggests lifestyle modification 
but with a lack of practical advice for both patients and 
families. It is the obligation of the clinician to provide both 
psychoeducation and life skills training to the young people 
without a standard description and protocol. Hence, the 
access to recurrence prevention service and quality of 
facilities are likely to be unequal even within the USA. There 
is an urgent need to standardize the clinical practice of 
psychoeducation which has evidence supporting the 
efficacy of recurrence prevention12 and there is a need to 
develop a well-organized protocol by using these studies 
as prototypes.
Conclusion 
 To date, no study has been published on the preven-
tion and intervention of recurrent depression in adolescents 
in Thailand. Even though the Thai CPG-MDD-GP is brief 
and practical, some particular dimensions such as psycho-
social intervention for the reduction of both depressive 
symptoms and recurrence prevention are not mentioned. 
The Thai CPG-MDD-GP guideline was derived from the 
guidelines of NICE (2013) and AACAP (2007), but it still 
lacks details for the family and community in treatment 
engagement as indicated from both prototypes (Table 2). 
Hence, further study of prevention of recurrence in depres-
sive adolescents is urgently needed to develop a current 
guideline to be more holistic and authentic in both the 
clinical and Thai socio-cultural contexts. Since standard 
guidelines such as the NICE and AACAP guidelines 
still highlight treatment considerations on the severity of 
depressive symptoms, the trajectory of depression and 
recurrence should be more in focus. Furthermore, the 
Figure 2 Depression management care pathway based on American Academy of Child and Adolescent Psychiatry17 
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upcoming Thai guideline for depression in the adolescent 
should emphasize family, school, and community-based 
surveillance with elaboration on the details of recommended 
psychological interventions for recurrence prevention with 
a longer period of clinical follow-up (i.e. more than 12-24 
months), especially in the high risk groups such as suicide, 
early onset depression or comorbidity of ADHD.
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